Carboplatin/Paclitaxel Clinical Trials

4 actively recruiting trials across 1 location

Also known as: CarboTaxol, Neoadjuvant Platin-Taxane Regimen (alternative 1), Neoadjuvant chemotherapy, PC

Pipeline

Phase 2: 3Phase 3: 1

Top Sponsors

The Netherlands Cancer Institute1
Shenyang Sunshine Pharmaceutical Co., LTD.1
Karolinska University Hospital1
AstraZeneca1

Indications

Cancer4
Lung Cancer2
Locally Advanced Penile Carcinoma1
First-line Advanced NSCLC Patients1
Urologic Neoplasms1

Other3 trials

A Phase II Study of SSGJ-706 Monotherapy and Combination Therapy in Advanced Non-Small Cell Lung Cancer（NSCLC） Patients

Phase 2

Carboplatin/Paclitaxel + Pembrolizumab for Locoregionally Advanced Penile Cancer

Phase 2

Chemoradiotherapy Followed by Planned Surgery or by Surveillance and Surgery Only When Needed for Oesophageal Cancer

Phase 3

Little Rock, Arkansas1 trial

Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer

Research Site

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.